MBM Wealth Consultants’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20
Closed -$120 289
2026
Q1
$120 Buy
+20
New +$150 ﹤0.01% 384
2023
Q2
Sell
-307
Closed -$7K 221
2023
Q1
$7K Hold
307
﹤0.01% 229
2022
Q4
$9K Buy
307
+96
+45% +$2.46K ﹤0.01% 233
2022
Q3
$5K Hold
211
﹤0.01% 236
2022
Q2
$7K Sell
211
-57
-21% -$2K ﹤0.01% 232
2022
Q1
$9K Hold
268
﹤0.01% 246
2021
Q4
$8K Hold
268
﹤0.01% 240
2021
Q3
$9K Hold
268
﹤0.01% 236
2021
Q2
$8K Buy
+268
New +$8.82K ﹤0.01% 226

Other funds holding OGN

MBM Wealth Consultants's OGN Position: Q2 2026 in Review

MBM Wealth Consultants sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 20 shares — an estimated $120 sold.

MBM Wealth Consultants first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $9K in Q4 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • MBM Wealth Consultants reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • MBM Wealth Consultants sold 20 Organon & Co shares in Q2 2026, an estimated $120.
  • MBM Wealth Consultants first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • MBM Wealth Consultants's Organon & Co position peaked at $9K in Q4 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on MBM Wealth Consultants's 13F filing for Q2 2026, filed 24 Jul 2026.